Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.62 |
| ▸ | CES1 | P23141 | 4/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.59 |
| ▸ | PPARG | P37231 | 7/20 | 0.59 |
| ▸ | PPARD | Q03181 | 7/20 | 0.59 |
| ▸ | PPARA | Q07869 | 7/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.59 |
| ▸ | TSHR | P16473 | 5/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | TLR2 | O60603 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | FABP4 | P15090 | 2/20 | 0.59 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.59 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | PDE4A | P27815 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11593048 | 1.00 | CES2 (0.62) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL6113345 | 1.00 | — | — | |
| SCHEMBL3624489 | 1.00 | CES2 (0.62) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL3888466 | 1.00 | CES2 (0.62) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL1716125 | 1.00 | CES2 (0.62) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL10886291 | 1.00 | CES2 (0.62) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL6912045 | 1.00 | CES2 (0.62) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL6250239 | 1.00 | CES2 (0.62) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL16777361 | 1.00 | CES2 (0.62) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL4120687 | 1.00 | CES2 (0.62) | CES2CES1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150171395-A1 | MODIFIED-CELLULOSE-NANOFIBER CONTAINING POLYETHYLENE FINE POROUS FILM, SEPARATOR, AND LITHIUM-ION BATTERY INCLUDING THE SAME | DAINIPPON INK & CHEMICALS (JP) | 2015-06-18 | — | — | US | disclosed |
| US-20140117286-A1 | COMPOSITION FOR PREPARING SEMICONDUCTOR NANOCRYSTAL PARTICLE, AND METHOD OF PREPARING SEMICONDUCTOR NANOCRYSTAL USING SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2014-05-01 | — | — | US | disclosed |
| US-20110021739-A1 | POLYCARBONATE RESIN | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-01-27 | — | — | US | disclosed |
| US-7511163-B2 | Creatine-fatty acids | MULTI FORMULATIONS LTD (CA) | 2009-03-31 | — | — | US | disclosed |
| EP-2011810-A1 | POLYCARBONATE RESIN | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
| WO-2008101310-A1 | CREATINE-FATTY ACIDS | MULTI FORMULATIONS LTD. (CA) | 2008-08-28 | — | — | WO | disclosed |
| WO-2008101313-A1 | PREPARATION OF AMINO ACID-FATTY ACID AMIDES | MULTI FORMULATIONS LTD. (CA) | 2008-08-28 | — | — | WO | disclosed |
| US-20080200704-A1 | PREPARATION OF AMINO ACID-FATTY ACID AMIDES | MULTI FORMULATIONS LTD. (CA) | 2008-08-21 | — | — | US | disclosed |
| US-20080200705-A1 | CREATINE-FATTY ACIDS | MULTI FORMULATIONS LTD. (CA) | 2008-08-21 | — | — | US | disclosed |
| US-7319157-B1 | Creatine-fatty acids | MULTI FORMULATIONS LTD. (CA) | 2008-01-15 | — | — | US | disclosed |
| EP-0289324-A1 | Method for racemization of optically active chrysanthemic acid derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-11-02 | — | — | EP | disclosed |
| EP-0115860-B1 | OPTICALLY ACTIVE 4-HYDROXY-2-CYCLOPENTENONES, AND THEIR PRODUCTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-10-12 | — | — | EP | disclosed |
| EP-0282221-A2 | Method for racemization of optically active chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-09-14 | — | — | EP | disclosed |
| US-4729953-A | 4-CYCLOPENTENONE ESTER, HYDROLYSIS, ENZYME OR MICROORGANISM, REARRANGEMENTS, CATALYSTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-03-08 | — | — | US | disclosed |
| US-4614546-A | INCLUDES AMINE-MODIFIED STARCH AND HYDROPHOBIC COMPOUNDS REACTIVE TO HYDROXY GROUPS | BAYER AKTIENGESELLSCHAFT (DE) | 1986-09-30 | — | — | US | disclosed |
| EP-0080671-B1 | 4-CYCLOPENTENONES AND THEIR PRODUCTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-08-21 | — | — | EP | disclosed |
| US-4511655-A | HYDROLYSIS WITH MICROORGANISM OR ENZYME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-04-16 | — | — | US | disclosed |
| EP-0115860-A2 | Optically active 4-hydroxy-2-cyclopentenones, and their production | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-08-15 | — | — | EP | disclosed |
| EP-0093321-A1 | Sizing agent based on ketene dimers | BAYER AG (DE) | 1983-11-09 | — | — | EP | disclosed |
| EP-0080671-A1 | 4-Cyclopentenones and their production | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200704-A1 | PREPARATION OF AMINO ACID-FATTY ACID AMIDES | FABP2, FABP4, FABP1 | CES2 1029/4885CES1 394/4885GPR84 499/4885 |
| US-20080200705-A1 | CREATINE-FATTY ACIDS | CPT1B, FABP2, FABP1 | CES2 298/4885CES1 112/4885GPR84 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.